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The COVID-19 pandemic has led to a dramatic increase 
in patients presenting with type 1 respiratory failure. In 
order to protect our limited critical care capacity, we rapidly 
developed a new ward-based inpatient continuous positive 
airway pressure (CPAP) service with direct input from the 
respiratory, infectious diseases and critical care teams. Close 
collaboration between these specialties and new innovative 
solutions were required to facilitate this. CPAP equipment 
(normally reserved for domiciliary care) was adapted to reduce 
the pressure on our strained oxygen infrastructure. Side 
rooms on the infectious diseases ward were swiftly converted 
into new negative pressure areas using temporary installed 
ventilatory equipment, reducing the viral aerosol risk for staff. 
Novel patient monitoring solutions were used to protect staff 
while also ensuring patient safety. Staff training and specialist 
oversight was organised within days. The resulting service was 
successful, with over half (17/26 (65%)) of patients avoiding 
invasive ventilation.
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The challenges posed by COVID-19
COVID-19 poses an unprecedented challenge to healthcare and has 
necessitated innovative approaches to managing the surge in demand 
for specific services.1 This has been felt most acutely in critical care 
units where it was predicted  20–30% of COVID-19 patients admitted 
to hospital would require require invasive mechanical ventilation 
due to respiratory failure.2 A collaborative decision was made by the 
respiratory, infectious diseases and the critical care teams to develop 
a new ward-based continuous positive airway pressure (CPAP) service 
in an attempt to prevent the critical care services from being rapidly 
overwhelmed. Similar approaches have been undertaken globally as 
the pandemic has developed and we have been fortunate to learn 
from other centres’ experiences.3,4 The Royal Liverpool Hospital site 
(RLH), one of two large inner-city secondary care sites that form 
Liverpool University Hospitals NHS Foundation Trust (LUHFT), has a 
total capacity of 650 beds with 36 critical care beds, of which, 18 offer 
invasive ventilation. Prior to this, the hospital’s capacity to provide 
ward-based CPAP was limited to a critical care environment and one 
other specialised area (coronary care unit (CCU)).
There were significant barriers to facilitating this service in a 
timely manner during the evolving pandemic: the development 
and deployment of an appropriate area and equipment; the safe 
monitoring of patients receiving non-invasive ventilation (NIV); 
and mitigating the predicted increased risk of infection to staff. We 
describe our experiences of developing a new inpatient CPAP unit 
within days during the first stages of the evolving COVID-19 pandemic.
Potential solutions
Rapidly developing and deploying an inpatient CPAP 
suitable environment
The use of CPAP risks aerosolising SARS-COV-2 and is considered 
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Developing a CPAP service for COVID-19 patients
Health Organization guidance recommends that AGPs are 
performed in a negative pressure room with air exchanges greater 
than 10 cycles per hour to minimise the risk of cross-infection to 
staff.6The negative pressure side rooms on the isolation ward of 
the infectious diseases unit were identified as the best available 
area to perform ward based CPAP. The unit capacity was increased 
by six, to a total of 13 beds. This was achieved by converting the 
remaining side rooms into negative pressure areas through the 
installation of temporary industrial high-efficiency particulate 
absorbing (HEPA) filtered air purifying units, an innovative 
approach initially developed in the South Korean COVID-19 
outbreak. This equipment allows air to ventilate externally, 
creating the required 10–15 air changes per hour required for a 
clinical negative pressure zone. Fig 1 displays the temporary filter 
system in situ.
Standardised non-vented masks covering the patient’s nose and 
mouth were applied to ensure the staff were familiar with the new 
equipment. CPAP masks are typically vented so HEPA viral filters 
were fitted to the expiratory port of the circuit to reduce the viral 
aerosol risk as per the NHS guidance.6 A second viral filter was 
fitted directly onto the CPAP device. CPAP was initiated as per a 
dedicated standard operating procedure that has been described 
elsewhere.7 Dual oxygen ports were utilised as a rescue or bridge 
therapy when required to temporarily enable entrained oxygen 
flow rates beyond 15 L/minute.
Avoiding system-wide oxygen pressure drop
Another important consideration is the surging oxygen 
requirements for patients with COVID-19 and the strain that this 
can put on hospital oxygen systems and pipework.8 This is known to 
have almost occurred in at least one large UK hospital, temporarily 
closing the hospital to new admissions.9 CPAP using a pressure valve 
(such as the UCL–Ventura CPAP device) typically use oxygen as a 
driving gas to power the mechanism as well as to directly oxygenate 
the patient. A CPAP unit using this technology at full capacity risks 
rapidly overloading the hospital oxygen supply system, particularly 
if oxygen use elsewhere in the hospital is increased.
To minimise the demand on the hospital oxygen infrastructure, a 
standard electrically powered non-invasive ventilator (Philips A30), 
a device which is often reserved for domiciliary CPAP, was utilised 
with wall oxygen entrained into the circuit as per the Association 
for Respiratory Technology and Physiology (ARTP) guidance 
(Fig 2).10 The oxygen consumption of this ventilator is 30–40 L/
minute, which is 50–60% lower than the oxygen consumption 
of pressure valve-based machines used to deliver CPAP in the 
hospital. This equipment is readily available in many NHS trusts 
and, while it has less functionality when compared with ventilators 
used in a critical care setting, the relative simplicity of the machine 
made training staff easier.
New methods of patient monitoring
The Faculty of Intensive Care Medicine recommends a staffing 
ratio of 2:1 for patients requiring high-dependency unit level care, 
with similar levels recommended for NIV by the British Thoracic 
Society.11,12 Furthermore, the use of side rooms necessitated 
frequent donning and doffing of appropriate personal protective 
equipment (PPE). With staffing levels under pressure throughout 
the trust, and with predicted staff absence of up to 20% due to 
illness or self-isolation, maintaining this level of staffing ratio with 
appropriately trained individuals was not deemed feasible or 
sustainable.13
To mitigate for this, changes were made to reduce staffing 
demands. Remote video monitoring relaying patients’ vital signs to 
a central nursing station was installed, facilitating the observation 
of patients outside their individual negative pressure rooms. 
Patients provided verbal consent to real-time video monitoring on 
admission and its use was checked by the information governance 
team prior to installation to ensure it complied with trust guidance. 
No images were stored, and the real-time image could be turned 
off when required. Non-invasive monitoring was possible as the 
predominant issue was respiratory failure and vasopressors were 
not required. Video monitoring had the added advantage of 
restricting unnecessary PPE use at a time when hospital stock 
levels were precarious.
Fig 1. Temporary high-efficiency particulate absorbing filter in place 
to create a negative pressure environment.
Fig 2. Domiciliary continuous positive airway pressure machine fitted 
with high-efficiency particulate absorbing filters.
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Ensuring staffing levels and providing sufficient training
The ward was staffed by a team consisting of both respiratory 
and infectious diseases healthcare workers with direct input from 
a multidisciplinary team with experience in ventilation. To protect 
staff from COVID-19 AGPs, level 2 PPE was used, as per the latest 
Public Health England (PHE) guidance, and they were required 
to complete competencies in donning and doffing PPE before 
being involved in patient care.14 Specific training and attenuated 
NIV competencies, based on the standardised equipment and 
using trainers attending ward areas, were taken to avoid further 
exacerbating staff shortages. Both the respiratory and infectious 
diseases teams performed a combined twice daily ward round 
with extra consultant cover out of hours. Patients were assessed by 
the critical care team prior to transfer to the CPAP ward, enabling 
the rapid escalation of patients for invasive mechanical ventilation 
where deemed appropriate.
Results so far
Since the development of this service, 31 patients have received 
ward-based CPAP, of which, five patients were deemed not for 
intubation at the onset of CPAP. Over half (17/26 (65%)) of 
patients avoided intubation through the use of CPAP; all have 
since been discharged. The median time on CPAP was 4 days 
(range 2–5). Eleven out of 26 (35.5%) patients failed the trial of 
CPAP and required invasive mechanical ventilation in the intensive 
care unit. The median time to intubation in this group was 6 hours. 
Of the five patients deemed unsuitable for intubation, 2/5 (40%) 
were weaned off CPAP and have subsequently been discharged, 
and 3/5 (60%) died. During this period, there were no serious 
adverse events related to the provision of this CPAP service. A full 
description and further analysis of outcomes for this cohort have 
been described elsewhere.7
The number of patients requiring acute CPAP due to COVID-19 
remained manageable with the described adaptions throughout 
the pandemic and, while significant, was less than the initial 
local modelling predictions. At the peak on 7 April 2020, we had 
a total of 209 COVID-19 inpatients across the trust. In our early 
experience, if CPAP is going to be ineffective this will become clear 
within the first 6 hours after initiation and case selection is critical. 
Larger multicentre studies are now ongoing to further clarify the 
optimal ventilation strategy in COVID-19 with respiratory failure.15
Potential future
This new service was developed within a period of days to manage 
an unclear but possibly very large number of patients during 
the first wave of the 2020 COVID-19 pandemic. To enable this, 
we accepted staffing ratios that, outside the context of a global 
pandemic, would be considered less than ideal. The use of CPAP in 
the management of COVID-19 remains disputed, however, from 
our limited local data thus far it appears to reduce the number of 
patients who would have otherwise required invasive mechanical 
ventilation.
We have overcome significant clinical and logistical barriers 
which, in a pre-pandemic setting, would have appeared 
insurmountable. Box 1 shows our key learning points. As 
admissions with severe COVID-19 reduced locally, the need for this 
intervention decreased and the CPAP service returned to critical 
care areas. However, when case numbers increased dramatically 
in our locality during October 2020 this service was urgently 
re-established within a 24-hour period. Sustainability in staffing 
has been prioritised with the development of a comprehensive 
CPAP training programme for new and existing staff, ensuring 
the essential skill set required remains available. Contingency 
plans have been developed to open larger temporary negative 
pressure areas if required. As the UK COVID-19 epidemic continues 
to evolve, this service will need to retain its flexibility to ensure it 
continues to be responsive to patient needs. ■
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